Back to Pictet Asset Management Holding SA Pictet Asset Management Holding SA

NRIXNRIX
12 quarters

Position history for Pictet Asset Management Holding SAPictet Asset Management Holding SA's holdings in NURIX THERAPEUTICS INC

Yes. Pictet Asset Management Holding holds 2,351,232 shares of NRIX (Nurix Therapeutics), worth $57M, as of its Q2 2026 13F filing. It reduced the position by 374,906 shares (-13.8%) from Q1 2026. Pictet Asset Management Holding has held NRIX in every 13F on record since Q3 2023, 12 quarterly filings. NRIX is 0.1% of Pictet Asset Management Holding's reported 13F portfolio.

Current Value

$57M

Current Shares

2.4M

Total Value Change

+$50M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.4M
-13.8%
$57M0.1%$24.26
0
2026-Q1
Decreased
2.7M
-21.4%
$42.3M0.0%$15.81
0
2025-Q4
Increased
3.5M
+75.1%
$65.8M0.1%$19.02
45
2025-Q3
Decreased
2M
-0.9%
$18.3M0.0%$9.28
0
2025-Q2
Increased
2M
+13.9%
$22.8M0.0%$11.64
32
2025-Q1
Decreased
1.8M
-0.8%
$20.8M0.0%$12.15
0
2024-Q4
Decreased
1.8M
-1.1%
$33.3M0.0%$18.64
0
2024-Q3
Increased
1.8M
+52.4%
$40.2M0.0%$23.05
41
2024-Q2
Increased
1.2M
+61.4%
$24.5M0.0%$20.87
41
2024-Q1
Decreased
726,941
-6.0%
$10.7M0.0%$14.70
0
2023-Q4
Decreased
773,588
-13.8%
$8M0.0%$10.32
0
2023-Q3
First report
897,809
-
$7.1M0.0%$7.86
0

Other major holders of NRIX: BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used